论文部分内容阅读
日前,由浙江大学附属一院传染病诊治国家重点实验室李兰娟院士领衔、联合香港大学新发传染病国家重点实验室等多家单位协同攻关的人感染H7N9禽流感病毒疫苗株研制成功。这是我国自主研发的首例流感病毒疫苗株,该病毒疫苗种子株已通过中国医学科学院医学实验动物研究所新药安全评价研究中心的安全性雪貂评价实验。检测结果显示,该病毒疫苗株的致病性较野生型H7N9毒株显著下降,与高
Recently, the First Affiliated Hospital of Zhejiang University, led by the State Key Laboratory of Infectious Disease Diagnosis and Treatment led by Academician Li Lanjuan, the Joint Hong Kong University State Key Laboratory of Emerging Infectious Diseases and many other units collaborative research people infected with H7N9 bird flu virus vaccine developed. This is the first influenza virus vaccine strain independently developed in China. The virus vaccine seed strain has passed the safety ferreting evaluation experiment by the New Drug Safety Evaluation Research Center of Institute of Medical Laboratory Animal Science, Chinese Academy of Medical Sciences. The test results showed that the virulence of the vaccine strain was significantly lower than that of the wild type H7N9 strain,